Conduit Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	5.17	3.05	2.89
Research & Development	0.09	0.04	0.03
Other Operating Expenses	0	0.07	0.26
Operating Expenses	5.26	3.16	3.17
Operating Income	-5.26	-3.16	-3.17
Interest Expense / Income	0.21	0	0
Other Expense / Income	-4.94	1.73	0.48
Pretax Income	-0.54	-4.89	-3.66
Net Income	-0.54	-4.89	-3.66
Shares Outstanding (Basic)	67	37	1,000
Shares Outstanding (Diluted)	68	37	1,000
Shares Change	81.30%	-96.26%	-
EPS (Basic)	-0.01	-0.13	-3657.00
EPS (Diluted)	-6056.00	-4887.00	-3657.00
Free Cash Flow	-7.73	-2.27	-2.15
Free Cash Flow Per Share	-0.12	-0.06	-0.00
EBITDA	-0.32	-4.89	-3.66
EBIT	-0.32	-4.89	-3.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).